Wu, Y., Chen, T., Wu, S., Huang, Y., & Li, F. (2025). Knockdown of RFC3 enhances the sensitivity of colon cancer cells to oxaliplatin by inducing ferroptosis. Fundamental & Clinical Pharmacology, 39(1), 1. https://doi.org/10.1111/fcp.13044
Chicago Style (17th ed.) CitationWu, Youyi, Tingting Chen, Songsong Wu, Yiwei Huang, and Fuyao Li. "Knockdown of RFC3 Enhances the Sensitivity of Colon Cancer Cells to Oxaliplatin by Inducing Ferroptosis." Fundamental & Clinical Pharmacology 39, no. 1 (2025): 1. https://doi.org/10.1111/fcp.13044.
MLA (9th ed.) CitationWu, Youyi, et al. "Knockdown of RFC3 Enhances the Sensitivity of Colon Cancer Cells to Oxaliplatin by Inducing Ferroptosis." Fundamental & Clinical Pharmacology, vol. 39, no. 1, 2025, p. 1, https://doi.org/10.1111/fcp.13044.